Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia

Schizophrenia Research

Volumn 76, Issue 1, 2005, Pages 83-87

  Skinner, Andrew O ^a   Mahadik, Sahebarao P ^b   Garver, David L ^a  

^a University of Louisville School of Medicine   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cerebrospinal fluid (CSF); Essential polyunsaturated fatty acid (EPUFA); Peroxidation; Phospholipids; Schizophrenia; Thiobarbituric acid reactive substances (TBARS)

Indexed keywords

THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BRAIN DEGENERATION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; GENDER; HUMAN; LIPID BLOOD LEVEL; MALE; NERVE CELL MEMBRANE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; COLORIMETRY; FATTY ACIDS, ESSENTIAL; FATTY ACIDS, UNSATURATED; FEMALE; FREE RADICALS; HUMANS; LIPID PEROXIDATION; MALE; MEMBRANE LIPIDS; REFERENCE VALUES; SCHIZOPHRENIA; SYNAPTIC MEMBRANES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 20444482775     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.10.010     Document Type: Article

References (19)

1. S. Arlt, U. Beisiegel, and A. Kontush Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease Current Opinion in Lipidology 13 2002 289 294
2. M. Arvindakahan, S. Sitasawad, V. Debsikdar, M. Ghate, D. Evans, D.F. Horrobin, C. Bennett, P.K. Ranjekar, and S.P. Mahadik Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients Biological Psychiatry 53 2003 56 64
3. G. Bartzokis, K.H. Nuechterlein, P.H. Lu, M. Gitlin, S. Rogers, and J. Mintz Dysregulated brain development in adult men with schizophrenia: a magnetic resonance study Biological Psychiatry 53 2003 412 421
4. D.F. Braus, G. Ende, W. Weber-Fahr, T. Demirakca, H. Tost, and F.A. Henn Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia European Neuropsychopharmacology 12 2003 145 152
5. J.R. Bustillo, J. Lauriello, L.M. Rowland, L.M. Thomson, H. Petropoulos, R. Hammond, B. Hart, and W.M. Brooks Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure Schizophrenia Research 58 2002 313 321
6. J. Christensen, J. Holcomb, and D.L. Garver State-related changes in cerebral white matter may underlie psychosis exacerbation Psychiatry Research. Neuroimaging 130 2004 71 78
7. K.L. Davis, D.G. Stewart, J.I. Friedman, M. Buchsbaum, P.D. Harvey, P.R. Hof, J. Buxbaum, and V. Haroutunian White matter changes in schizophrenia: evidence for myelin-related dysfunction Archives of General Psychiatry 60 2003 443 456
8. D. Fannon, A. Simmons, L. Tennakoon, S. O'Ceallaigh, A. Sumich, V. Doku, C. Shew, and T. Sharma Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naïve patients with schizophrenia Biological Psychiatry 54 2003 587 598
9. S.W. Flynn, D.J. Lang, A.L. Mackay, V. Goghari, I.M. Vavasour, K.P. Whittall, G.N. Smith, V. Arango, J.J. Mann, A.J. Dwork, P. Falkai, and W.G. Honer Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post mortem analysis of oligodendrocyte proteins Molecular Psychiatry 8 2003 811 820
10. A. Greco, L. Minghetti, and G. Levi Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases Neurochemical Research 25 2002 1357 1364
11. M.I. Hunter, B.D. Nlemadim, and D.L. Davidson Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients Neurochemical Research 10 1985 1645 1652
12. D.R. Janero Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury Free Radical Biology & Medicine 9 1990 515 540
13. M.M. Khan, D.R. Evans, V. Gunna, R.E. Scheffer, V.V. Parikh, and S.P. Mahadik Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics Schizophrenia Research 58 2002 1 10
14. J.B. Lohr, R. Kuczenski, H.S. Bracha, M. Moir, and D.V. Jeste Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia Biological Psychiatry 28 1990 535 539
15. S.P. Mahadik, S. Mukherjee, R. Scheffer, E.E. Correnti, and J.S. Mahadik Elevated plasma lipid peroxidases at the onset of nonaffective psychosis Biological Psychiatry 43 1998 674 679
16. T.J. Montine, M.D. Neelt, J.F. Quinn, M.F. Beal, W.R. Markesbery, L.J. Roberts, and J.D. Morrow Lipid peroxidation in aging brain and Alzheimer's disease Free Radical Biology & Medicine 33 2002 620 626
17. R. Naidoo, and M.L. Knapp Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions Clinical Chemistry 38 1992 2449 2454
18. H.S. Pall, A.C. Williams, D.R. Blake, and J. Lunec Evidence of enhances lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines Lancet 2 1987 596 599
19. N.A. Simonian, and J.T. Coyle Oxidative stress in neurodegenerative diseases Annual Review of Pharmacology and Toxicology 36 1966 82 106